Edition:
United States

Sarepta Therapeutics Inc (SRPT.OQ)

SRPT.OQ on NASDAQ Stock Exchange Global Select Market

119.52USD
14 Dec 2018
Change (% chg)

$-2.50 (-2.05%)
Prev Close
$122.02
Open
$120.57
Day's High
$123.14
Day's Low
$118.95
Volume
183,515
Avg. Vol
334,180
52-wk High
$176.44
52-wk Low
$50.68

Chart for

About

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne... (more)

Overall

Beta: 1.28
Market Cap(Mil.): $3,262.29
Shares Outstanding(Mil.): 64.33
Dividend: --
Yield (%): --

Financials

  SRPT.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -2.44 -- --
ROI: -47.63 9.01 14.96
ROE: -49.74 10.15 16.52

Sarepta shares soar as Duchenne gene therapy shows promise

Sarepta Therapeutics' shares jumped 60 percent on Tuesday after promising results from a gene therapy study positioned the specialty drugmaker as a potential leader in the market for Duchenne muscular dystrophy (DMD) treatments.

Jun 19 2018

UPDATE 3-Sarepta shares soar as Duchenne gene therapy shows promise

* Sarepta shares rise as much as 67.7 percent (Adds details on study results, updates share price)

Jun 19 2018

Earnings vs. Estimates